The endogenous expression of Gal-9 did not associate with sensitivity to treatment with exogenous Gal-9 in either cell lines or patient-derived AML samples (Supplementary Fig. 4F, G). The gene discussed is LGALS9; the disease is acute myeloid leukemia.